Kevin Fiala focuses his practice in the area of life sciences, particularly in the fields of biochemistry, molecular biology, immunology, protein therapeutics, gene therapy and stem cell therapy. Kevin assists clients with the preparation and prosecution of patent applications, competitive landscape analyses, and due diligence evaluations.
Prior to joining the firm, Kevin was a patent agent at McCarter & English, LLP. He also worked at MIT’s Technology Licensing Office where he evaluated new inventions across a wide range of technical fields.
A recipient of the American Cancer Society Post-doctoral Fellowship, Kevin did his post-doctoral research at the Department of Chemistry and Chemical Biology at Harvard University, where his research focused primarily in the area of molecular and cellular biology. During his tenure in academic research, he was the recipient of numerous grants and fellowships, including the National Institutes of Health Chemistry-Biology Interface Program Pre-doctoral Training Grant and the American Heart Association Pre-doctoral Fellowship. He has published more than 15 scientific research articles and book chapters and has presented his work at numerous international scientific meetings.
Boston Patent Law Association